__NUXT_JSONP__("/drugs/FarnesyltransferaseGeranylgeranyltransferase_Inhibitor_L-778123", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"253863-00-2",chebiId:b,chemicalFormula:b,definition:"A benzonitrile derivative capable of inhibiting some prenyltransferases. L-778,123 is a dual inhibitor of farnesyl:protein and geranylgeranyl:protein transferases; both enzymes catalyze prenylation of oncoprotein KRAS, a prerequisite step in activation of KRAS in signal transduction pathway of apoptosis. Although this agent was developed in part as an anti-KRAS agent, L-778,123 failed in a Phase I trial to inhibit KRAS, which is associated with many types of solid tumors.",fdaUniiCode:"2A2059P49U",identifier:"C1840",preferredName:c,semanticType:"Organic Chemical",subclassOf:["C2020"],synonyms:["4-[[5-[[4-(3-Chlorophenyl)-3-oxo-1-piperazinyl]methyl]-1H-imidazol-1-yl]methyl]benzonitrile Monohydrochloride",c,"L 778123","L-778,123","L-778123"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FFarnesyltransferaseGeranylgeranyltransferase_Inhibitor_L-778123",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("FarnesyltransferaseGeranylgeranyltransferase_Inhibitor_L-778123","","Farnesyltransferase\u002FGeranylgeranyltransferase Inhibitor L-778,123","2021-10-30T13:36:51.443Z")));